Illness	Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	325
Malignant neoplasm of prostate (C61)	316
Hyperplasia of prostate (N40)	283
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	262
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	185
Calculus of kidney and ureter - Calculus of ureter (N20.1)	108
Malignant neoplasm of kidney except renal pelvis (C64)	100
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	90
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	88
Unspecified haematuria (R31)	86

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.x)	3.879
Injection or administration of medicines into the urinary bladder (8-132.3)	805
Examination of the urethra and the urinary bladder by endoscopy (1-661)	449
Insertion, exchange or removal of a ureteral stent (8-137.00)	421
(1-999.40)	333
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	311
(9-984.7)	290
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	286
Operation using a surgical robot (5-987.0)	221
(9-984.8)	204

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ27
CQ25
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
92	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
66	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
64	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities